| Jacqueline Muhammad, MD | |
|
600 Moye Blvd, Greenville, NC 27834-4300 | |
| (252) 744-2350 | |
| (252) 744-5348 |
| Full Name | Jacqueline Muhammad |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 600 Moye Blvd, Greenville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669690210 | NPI | - | NPPES |
| ABOG-MOC | Other | AMERICAN BOARD OF OBSTETRICS AND GYNECOLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 53325 (Wisconsin) | Secondary |
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 2014-01261 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Carolina University | 0244143246 | 362 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
| Entity Name | East Carolina University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972551919 PECOS PAC ID: 0244143246 Enrollment ID: O20031106000400 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
| Entity Name | Southeastern Regional Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427282045 PECOS PAC ID: 7012058548 Enrollment ID: O20100106000556 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
| Entity Name | Wakemed Specialists Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588227839 PECOS PAC ID: 2466788377 Enrollment ID: O20190731000815 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Muhammad, MD Po Box 751069, Charlotte, NC 28275-1069 Ph: () - | Jacqueline Muhammad, MD 600 Moye Blvd, Greenville, NC 27834-4300 Ph: (252) 744-2350 |
News Archive
Close2U, an electronic device application, has been developed by researchers at the Complutense University (UCM) and the University of Zaragoza (UZA) to monitor cancer patients' physical and mental health using gamification.
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild's safety, with no reports of patient complications related to the procedure or the devices.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
› Verified 1 days ago
Eric Arthur Deigan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-2350 Fax: 252-744-5348 | |
Dr. Sarah Elizabeth Smith, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Moye Blvd, Ecu Physicians Ob/gyn, Greenville, NC 27834 Phone: 252-744-2350 Fax: 252-744-2967 | |
Dr. Jason Paul Hildebrand, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-2350 Fax: 252-744-2967 | |
Dr. James E Devente, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-3850 Fax: 252-744-3894 | |
Hale Stephenson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Bethesda Dr, Greenville, NC 27834 Phone: 252-758-4181 Fax: 252-758-2603 | |
Donald Paul Shackelford, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Greenville, NC 27834 Phone: 252-847-2273 | |
Frank Gay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Bethesda Dr, Greenville, NC 27834 Phone: 252-758-4181 Fax: 252-758-2603 |